ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,192.00
      -0.44%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.835
      0.35%
      Bitcoin
      62,615.36
      -0.37%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neurobiological Technologies (MM) (NTII)

      7. Neurobiological Technologies (MM) (NTII) News

      NTII

      Neurobiological (NTII)

      Neurobiological Technologies (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NTII
      DateTimeSourceHeadlineSymbolCompany
      11/17/20081:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/17/20081:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/17/20081:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/17/20081:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/17/20081:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/14/20082:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/13/200812:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/10/20084:10PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
      11/06/20084:13PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NTIINeurobiological Technologies (MM)
      11/06/20086:30AMPR Newswire (US)Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
      11/06/20086:04AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      11/05/20084:08PMEdgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:NTIINeurobiological Technologies (MM)
      11/05/20087:00AMPR Newswire (US)Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10NASDAQ:NTIINeurobiological Technologies (MM)
      11/04/20086:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/04/20086:30AMPR Newswire (US)Neurobiological Technologies Sets Date for First Quarter Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
      11/03/20087:00AMPR Newswire (US)Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of MemantineNASDAQ:NTIINeurobiological Technologies (MM)
      10/30/200812:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      10/27/20088:30AMPR Newswire (US)Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008NASDAQ:NTIINeurobiological Technologies (MM)
      10/23/200810:54AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      10/20/20085:24PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
      10/20/20085:17PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTIINeurobiological Technologies (MM)
      10/16/20087:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      10/14/20086:02AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      10/13/20087:30AMPR Newswire (US)Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal DataNASDAQ:NTIINeurobiological Technologies (MM)
      10/10/20084:00PMPR Newswire (US)Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial ProgramNASDAQ:NTIINeurobiological Technologies (MM)
      10/09/200811:40AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NTIINeurobiological Technologies (MM)
      09/25/20086:00AMPR Newswire (US)Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 ClinicalNASDAQ:NTIINeurobiological Technologies (MM)
      09/18/20088:30AMPR Newswire (US)Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLCNASDAQ:NTIINeurobiological Technologies (MM)
      09/17/20082:06PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:NTIINeurobiological Technologies (MM)
      09/16/20081:02PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Annual Report (10-K)NASDAQ:NTIINeurobiological Technologies (MM)
       Showing the most relevant articles for your search:NASDAQ:NTII